Atlas Trials

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Clinical trial NCT00138151 · TERMINATED

Trial details

NCT number
NCT00138151
Sponsor
University of Medicine and Dentistry of New Jersey
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2001-03-01
Primary completion
2010-11-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.